143 related articles for article (PubMed ID: 23665303)
1. Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China.
Cook MC; Gibeault S; Filippenko V; Ye Q; Wang J; Kunkel JP
Biologicals; 2013 Jul; 41(4):261-8. PubMed ID: 23665303
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: optimisation of hydrolysis conditions and chromatographic methods.
Cook MC; Bliu A; Kunkel JP
Vaccine; 2013 Aug; 31(36):3702-11. PubMed ID: 23764533
[TBL] [Abstract][Full Text] [Related]
3. Quantification of each serogroup polysaccharide of Neisseria meningitidis in A/C/Y/W-135-DT conjugate vaccine by high-performance anion-exchange chromatography-pulsed amperometric detection analysis.
Gudlavalleti SK; Crawford EN; Harder JD; Reddy JR
Anal Chem; 2014 Jun; 86(11):5383-90. PubMed ID: 24810004
[TBL] [Abstract][Full Text] [Related]
4. Quantification of free polysaccharide in meningococcal polysaccharide-diphtheria toxoid conjugate vaccines.
Lei QP; Shannon AG; Heller RK; Lamb DH
Dev Biol (Basel); 2000; 103():259-64. PubMed ID: 11214246
[TBL] [Abstract][Full Text] [Related]
5. Relative stability of meningococcal serogroup A and X polysaccharides.
Berti F; Romano MR; Micoli F; Pinto V; Cappelletti E; Gavini M; Proietti D; Pluschke G; MacLennan CA; Costantino P
Vaccine; 2012 Oct; 30(45):6409-15. PubMed ID: 22921741
[TBL] [Abstract][Full Text] [Related]
6. Development of four sandwich ELISAs for quantitation of capsular polysaccharides from Neisseria meningitidis serogroups A, C, W and Y in multivalent vaccines.
Reyes F; Otero O; Cuello M; Amin N; García L; Cardoso D; Camacho F
J Immunol Methods; 2014 May; 407():58-62. PubMed ID: 24727145
[TBL] [Abstract][Full Text] [Related]
7. A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines.
Reyes F; Otero O; Camacho F; Amin N; Ramírez F; Valdés Y; Acevedo R; García L; Cardoso D; Cuello M
Biologicals; 2014 Nov; 42(6):312-5. PubMed ID: 25218518
[TBL] [Abstract][Full Text] [Related]
8. Acid hydrolysis conditions for quantification of meningococcal X polysaccharide in a pentavalent vaccine using HPAEC-PAD/ESI-MS.
Ghosh S; Pawar R; Kangralkar V; Mallya AD; Dhere RM; Bolgiano B; Ravenscroft N
Anal Biochem; 2023 Dec; 683():115363. PubMed ID: 37866526
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
[TBL] [Abstract][Full Text] [Related]
10. Determination of meningococcal polysaccharides by capillary zone electrophoresis.
Lamb DH; Lei QP; Hakim N; Rizzo S; Cash P
Anal Biochem; 2005 Mar; 338(2):263-9. PubMed ID: 15745746
[TBL] [Abstract][Full Text] [Related]
11. An integrity assay for a meningococcal type B conjugate vaccine.
Turula VE; Kim J; Michon F; Pankratz J; Zhang Y; Yoo C
Anal Biochem; 2004 Apr; 327(2):261-70. PubMed ID: 15051544
[TBL] [Abstract][Full Text] [Related]
12. Meningococcal vaccines.
Danzig L
Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S285-92. PubMed ID: 15597071
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
[TBL] [Abstract][Full Text] [Related]
14. Determination of meningococcal serogroups in formulated monovalent and multivalent polysaccharide and polysaccharide-conjugate vaccines.
Cook MC; Kunkel JP
Anal Chem; 2015 May; 87(9):5009-11. PubMed ID: 25837841
[No Abstract] [Full Text] [Related]
15. Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidis groups Y and W135.
Bardotti A; Averani G; Berti F; Berti S; Galli C; Giannini S; Fabbri B; Proietti D; Ravenscroft N; Ricci S
Vaccine; 2005 Mar; 23(16):1887-99. PubMed ID: 15734061
[TBL] [Abstract][Full Text] [Related]
16. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
Cohen R; Levy C
Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
[TBL] [Abstract][Full Text] [Related]
17. Humoral and cellular immune responses induced by serogroup W135 meningococcal conjugate and polysaccharide vaccines.
Cheng Y; Shen R; Liu F; Li Y; Wang J; Hou Y; Liu Y; Zhou H; Hou F; Wang Y; Li X; Qiao R; Luo S
Vaccine; 2024 Apr; 42(11):2781-2792. PubMed ID: 38508928
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) using sandwich ELISA.
Phugare S; Kale S; Sharma P; Kumar Goel S; Gairola S; Jadhav SS
Vaccine; 2020 Nov; 38(49):7815-7824. PubMed ID: 33164804
[TBL] [Abstract][Full Text] [Related]
19. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
El Bashir H; Heath PT; Papa T; Ruggeberg JU; Johnson N; Sinha R; Balfour G; Booy R
Vaccine; 2006 Mar; 24(14):2544-9. PubMed ID: 16417952
[TBL] [Abstract][Full Text] [Related]
20. Development of a new method for the quantitative analysis of the extracellular polysaccharide of Neisseria meningitidis serogroup A by use of high-performance anion-exchange chromatography with pulsed-amperometric detection.
Ricci S; Bardotti A; D'Ascenzi S; Ravenscroft N
Vaccine; 2001 Feb; 19(15-16):1989-97. PubMed ID: 11228369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
